Adenocarcinoma of lung (disorder)
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Three of the nine-examined early EMT hallmark genes, GALNT6, SPARC and HES7, were up-regulated specifically in the early stages of lung adenocarcinoma (LUAD) and confirmed by TCGA patient transcriptome data.
|
31296175 |
2019 |
Malignant Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
Finally, we observed that basal expression of CSC-related genes (ID1, CD44, HES7 and TCF3) significantly correlate with ONC201 efficacy in >1000 cancer cell lines and combining the expression of multiple genes leads to a stronger overall prediction.
|
28767654 |
2017 |
Primary malignant neoplasm
|
0.010 |
Biomarker
|
group |
BEFREE |
Finally, we observed that basal expression of CSC-related genes (ID1, CD44, HES7 and TCF3) significantly correlate with ONC201 efficacy in >1000 cancer cell lines and combining the expression of multiple genes leads to a stronger overall prediction.
|
28767654 |
2017 |
Dextrocardia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
A novel homozygous missense mutation c.1451A > C (p.H484P) in exon 9 of the CTC1 gene and a rare 3'UTR known dbSNP variation (c.*556 T > C) in HES7 were identified as the plausible candidates associated with this complex phenotype of Coats plus and dextrocardia.
|
25928698 |
2015 |
CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS (disorder)
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Whole exome sequencing in an Indian family links Coats plus syndrome and dextrocardia with a homozygous novel CTC1 and a rare HES7 variation.
|
25928698 |
2015 |
Dextrocardia with situs inversus
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Mutation of HES7 in a large extended family with spondylocostal dysostosis and dextrocardia with situs inversus.
|
23897666 |
2013 |
Dysmorphic features
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
There were no other significant organ abnormalities, no obvious dysmorphic features, neurodevelopment was normal, and all investigations, including mutation analysis of DLL3, MESP2, LFNG, and HES7, were normal.
|
20503311 |
2010 |
Dysostoses
|
0.010 |
GeneticVariation
|
disease |
LHGDN |
Mutation of Hairy-and-Enhancer-of-Split-7 in humans causes spondylocostal dysostosis.
|
18775957 |
2008 |
Anemia, Sickle Cell
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
In this study, we have identified two new missense mutations in the HES7 gene in a single family, with only individuals carrying both mutant alleles being affected by SCD.
|
20087400 |
2010 |
Renal carnitine transport defect
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
In this study, we have identified two new missense mutations in the HES7 gene in a single family, with only individuals carrying both mutant alleles being affected by SCD.
|
20087400 |
2010 |
Anemia, Sickle Cell
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Here we have used autozygosity mapping to identify a mutation in a fourth Notch pathway gene, Hairy-and-Enhancer-of-Split-7 (HES7), in an autosomal recessive SCD family.
|
18775957 |
2008 |
Renal carnitine transport defect
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Here we have used autozygosity mapping to identify a mutation in a fourth Notch pathway gene, Hairy-and-Enhancer-of-Split-7 (HES7), in an autosomal recessive SCD family.
|
18775957 |
2008 |
Body Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Cleft Palate
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cryptorchidism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Dwarfism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Fetal Growth Retardation
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hernia, Inguinal
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Kyphosis deformity of spine
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Meningomyelocele
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Microcephaly
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Respiratory Insufficiency
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Scoliosis, unspecified
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Spina Bifida Occulta
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Syndactyly of fingers
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|